Gafita, Andrei http://orcid.org/0000-0002-4865-9192
Rauscher, Isabel
Fendler, Wolfgang P.
Murthy, Vishnu
Hui, Wang
Armstrong, Wesley R.
Herrmann, Ken
Weber, Wolfgang A.
Calais, Jeremie
Eiber, Matthias
Weber, Manuel
Benz, Matthias R.
Article History
Received: 19 April 2022
Accepted: 16 June 2022
First Online: 29 June 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The retrospective analysis was approved by the Ethics Committee of each participating site (TUM 115/18S, UCLA IRB #20–000954, UKE 19–8570-BO) which waived the necessity for study specific consent.
: ME reports fees from Blue Earth Diagnostics Ltd. (consultant, research funding), Novartis/AAA (consultant), Telix (consultant), Bayer (consultant, research funding), RayzeBio (consultant), Point Biopharma (consultant) and Janssen Pharmaceuticals (consultant, speakers bureau), Parexel (image review) and Bioclinica (image review) outside the submitted work and a patent application for rhPSMA. JCa reports prior consulting activities outside of the submitted work for Advanced Accelerator Applications, Blue Earth Diagnostics, Curium Pharma, GE Healthcare, IBA Radiopharma, Janssen Pharmaceuticals, POINT biopharma, Progenics Pharmaceuticals, Radiomedix, and Telix Pharmaceuticals. KH reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, personal fees from Bain Capital, and personal fees from MPM Capital outside the submitted work. WPF reports fees from SOFIE Bioscience (research funding), Janssen (consultant, speakers bureau), Calyx (consultant), Bayer (consultant, speakers bureau, research funding), Parexel (image review), and AAA (speakers bureau) outside of the submitted work. WAW was on advisory boards and received compensation from Bayer, Blue Earth Diagnostics, Endocyte, ITM, RayzeBio, and Pentixapharm. He has received research support from BMS, Imaginab, Ipsen, and Piramal. No other potential conflict of interest relevant to this article was reported.